DoW Breast Cancer, Transformative Breast Cancer Consortium Award
This grant funds multidisciplinary, multi-institutional consortia of scientists, clinicians, and advocates to collaboratively tackle major breast cancer challenges and drive transformative progress toward ending the disease.
Funder: Dept. of the Army -- USAMRAA
Due Dates: June 12, 2026: Pre-Application deadline | July 16, 2026: Invitation to submit full application (notification) | September 30, 2026: Full application deadline | October 5, 2026: End of application verification period
Funding Amounts: Up to $35,000,000 total for one award over a maximum of four years.
Summary: Supports a multidisciplinary, multi-institutional consortium to pursue transformative, innovative research addressing major challenges in breast cancer.
Key Information: Requires a consortium of up to five PIs and at least one breast cancer consumer advocate per project team; pre-application is mandatory.
Description
This opportunity funds the formation of a highly integrated, multidisciplinary, and multi-institutional consortium to address fundamental, high-impact challenges in breast cancer research. The award is intended to support collaborations that can significantly accelerate progress toward ending breast cancer, with the requirement to address at least one of the FY26 Breast Cancer Research Program (BCRP) overarching challenges or provide strong justification for addressing other key issues. The consortium must include leading scientists, clinicians, and breast cancer consumer advocates, and aims to deliver transformative change for individuals with, or at risk for, breast cancer.
